Apoptosis
Apoptosis, also known as programmed cell death, is rigorously controlled process of cell death that leads to phagocytosis of unwanted cell. It is triggered after sufficient cellular damage and activated through extrinsic or intrinsic pathways. The intrinsic pathway is mainly occurs via release of cytochrome c from the mitochondria and regulates mitochondrial outer membrane permeabilization by Bcl-2 family proteins. The extrinsic pathway is induced by ligand binding to death receptor, such as Fas, TNFαR, DR3, DR4, and DR5. Caspases then cleave target proteins and nuclear lamins to promote DNA degradation, resulting apoptotic cells undergo phagocytosis. In addition, p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some Inhibitors of apoptosis proteins (IAPs), such as XIAP/BIRC4 and Bruce/BIRC6, can block casapse activity through direct binding, while other IAPs, such as cIAP1/BIRC2, cIAP2/BIRC3, act as ubiquitin ligases that target caspases for ubiquitin-mediated degradation. Apoptosis is essential for growth, development and aging in multicellular organisms. Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases, including cancer.
-
BA3567 IratumumabSummary: Iratumumab (MDX-060) is a human IgG1κ monoclonal antibody against... - BA3568 TecaginlimabSummary: Tecaginlimab (BNT-312) is an Fc-inert bispecific antibody.
- BA3570 CDC801Summary: CDC801 is a potent inhibitor of phosphodiesterase 4 and tumor necrosis factor-α.
- BA3677 BOLD-100Summary: BOLD-100 (NKP-1339; IT-139) is a first-in-class ruthenium anticancer reagent developed for solid cancers with few side effects.
- BA2316 InotuzumabSummary: Inotuzumab (HumanizedAnti-CD22RecombinantAntibody) is humanized, κ-antibody targeted to humans.
- BA2326 TaltobulinSummary: Taltobulin (HTI-286) is a synthetic tripeptide cysteine analog, Taltobulin is a potent anti-microtubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
- BA2331 MaytansinolSummary: Maytansinol (AnsamitocinP-0) is a derivative of Medenin.
- BA2360 MensacarcinSummary: Mensacarcin is a highly complex polyketide that is commonly found in tumor cell lines to strongly inhibit cell growth and may induce apoptosis in melanoma cells.
- BA2627 McMMAFSummary: McMMAF is composed of the highly efficient microtubule inhibitor MonomethylF (MMAF) coupled with the protecting group maleimidocaproyl, which can be used as the active molecular linker.
- BA3744 OrobolSummary: Orobol is a major soy isoflavone with a variety of pharmacological activities, including anti-skin aging and anti-obesity effects.